Earnings calendar/HRTX
HERON THERAPEUTICS, INC. /DE/ (HRTX)
Quarter-by-quarter results read from the company's own filed statements — period end, filing date, diluted EPS, revenue and year-over-year change. Consensus estimates are shown only where one exists.
Latest filed quarter
The most recent quarter HERON THERAPEUTICS, INC. /DE/ has filed, from EvidInvest's standardized statements.
Period end
Jun 30, 2026
Q2 FY2026
EPS (diluted)
$-0.03
Est. $-0.01 · -500.0%
Revenue
$37.7M
Est. $42.2M · -10.7%
Net income
$-5.5M
As filed
EPS YoY
-50.0%
vs quarter ended 2025-06-30
Revenue YoY
+1.3%
vs quarter ended 2025-06-30
Next report
Nov 3, 2026
Scheduled · est. EPS $-0.03
Run-rate
Trailing twelve months, summed from the last four filed quarters.
TTM EPS (diluted)
$-0.18
2025-09-30 through 2026-06-30
TTM revenue
$151.2M
2025-09-30 through 2026-06-30
Filed quarters
40
On record here
EPS at or above estimate (4Q)
25%
Of the last four quarters that carry an estimate
Filed quarters
One row per filed statement, newest first
| Period end | Filed | EPS diluted | Revenue | EPS YoY | Revenue YoY | Est. EPS | Surprise |
|---|---|---|---|---|---|---|---|
| 2026-06-30Q2 FY2026 | 2026-08-10 | $-0.03 | $37.7M | -50.0% | +1.3% | $-0.01 | -500.0% |
| 2026-03-31Q1 FY2026 | 2026-05-11 | $-0.04 | $34.7M | -500.0% | -10.8% | $-0.03 | -33.3% |
| 2025-12-31Q4 FY2025 | 2026-02-26 | $-0.01 | $40.6M | -150.0% | -0.5% | $-0.03 | +66.7% |
| 2025-09-30Q3 FY2025 | 2025-11-04 | $-0.10 | $38.2M | -233.3% | +16.5% | $-0.01 | -651.9% |
| 2025-06-30Q2 FY2025 | 2025-08-08 | $-0.02 | $37.2M | +66.7% | +3.3% | $-0.01 | -100.0% |
| 2025-03-31Q1 FY2025 | 2025-05-06 | $0.01 | $38.9M | +150.0% | +12.2% | $-0.01 | +200.0% |
| 2024-12-31Q4 FY2024 | 2025-02-27 | $0.02 | $40.8M | +300.0% | +19.1% | $-0.03 | +166.7% |
| 2024-09-30Q3 FY2024 | 2024-11-12 | $-0.03 | $32.8M | +82.4% | +4.4% | $-0.03 | -9.1% |
| 2024-06-30Q2 FY2024 | 2024-08-06 | $-0.06 | $36.0M | +82.9% | +13.4% | $-0.04 | -50.0% |
| 2024-03-31Q1 FY2024 | 2024-05-07 | $-0.02 | $34.7M | +92.6% | +17.1% | $-0.08 | +75.0% |
| 2023-12-31Q4 FY2023 | 2024-03-12 | $-0.01 | $34.2M | +90.9% | +14.0% | $-0.15 | +93.3% |
| 2023-09-30Q3 FY2023 | 2023-11-14 | $-0.17 | $31.4M | +55.3% | +18.4% | $-0.31 | +45.2% |
| 2023-06-30Q2 FY2023 | 2023-08-14 | $-0.35 | $31.8M | +36.4% | +15.0% | $-0.23 | -52.2% |
| 2023-03-31Q1 FY2023 | 2023-05-11 | $-0.27 | $29.6M | +57.1% | +26.3% | $-0.17 | -58.8% |
| 2022-12-31Q4 FY2022 | 2023-03-29 | $-0.11 | $30.0M | +79.2% | +45.4% | $-0.25 | +56.0% |
| 2022-09-30Q3 FY2022 | 2022-11-08 | $-0.38 | $26.6M | +25.5% | +14.3% | $-0.39 | +2.6% |
| 2022-06-30Q2 FY2022 | 2022-08-09 | $-0.55 | $27.6M | +11.3% | +23.1% | $-0.50 | -10.0% |
| 2022-03-31Q1 FY2022 | 2022-05-09 | $-0.63 | $23.5M | -8.6% | +17.2% | $-0.45 | -40.0% |
| 2021-12-31Q4 FY2021 | 2022-02-28 | $-0.53 | $20.7M | +22.1% | +0.2% | $-0.59 | +10.2% |
| 2021-09-30Q3 FY2021 | 2021-11-03 | $-0.51 | $23.2M | +20.3% | +16.4% | $-0.60 | +15.0% |
| 2021-06-30Q2 FY2021 | 2021-08-09 | $-0.62 | $22.4M | -1.6% | -1.0% | $-0.59 | -5.1% |
| 2021-03-31Q1 FY2021 | 2021-05-10 | $-0.58 | $20.0M | -1.8% | -21.2% | $-0.57 | -1.8% |
| 2020-12-31Q4 FY2020 | 2021-02-24 | $-0.68 | $20.6M | -4.6% | -41.3% | $-0.68 | 0.0% |
| 2020-09-30Q3 FY2020 | 2020-11-05 | $-0.64 | $20.0M | -52.4% | -53.2% | $-0.65 | +1.5% |
| 2020-06-30Q2 FY2020 | 2020-08-05 | $-0.61 | $22.7M | +3.2% | -38.2% | $-0.59 | -3.4% |
| 2020-03-31Q1 FY2020 | 2020-05-06 | $-0.57 | $25.4M | +28.8% | -19.6% | $-0.63 | +9.5% |
| 2019-12-31Q4 FY2019 | 2020-03-02 | $-0.65 | $35.1M | -3.2% | +21.6% | $-0.58 | -12.1% |
| 2019-09-30Q3 FY2019 | 2019-11-12 | $-0.42 | $42.6M | +14.3% | +115.4% | $-0.60 | +30.0% |
| 2019-06-30Q2 FY2019 | 2019-08-05 | $-0.63 | $36.7M | -16.7% | +112.2% | $-0.68 | +7.4% |
| 2019-03-31Q1 FY2019 | 2019-05-09 | $-0.80 | $31.6M | +1.2% | +173.2% | $-0.47 | -70.2% |
| 2018-12-31Q4 FY2018 | 2019-02-22 | $-0.63 | $28.8M | +42.2% | +186.9% | $-0.46 | -37.0% |
| 2018-09-30Q3 FY2018 | 2018-11-07 | $-0.49 | $19.8M | +36.4% | +130.8% | $-0.47 | -4.3% |
| 2018-06-30Q2 FY2018 | 2018-08-08 | $-0.54 | $17.3M | +32.5% | +103.0% | $-0.69 | +21.7% |
| 2018-03-31Q1 FY2018 | 2018-05-10 | $-0.81 | $11.6M | +19.0% | +218.5% | $-0.82 | +1.2% |
| 2017-12-31Q4 FY2017 | 2018-02-27 | $-1.09 | $10.1M | +10.7% | +686.0% | $-0.78 | -39.7% |
| 2017-09-30Q3 FY2017 | 2017-11-06 | $-0.77 | $8.6M | +37.9% | +1196.8% | $-0.87 | +11.5% |
| 2017-06-30Q2 FY2017 | 2017-08-09 | $-0.80 | $8.5M | — | — | $-0.95 | +15.8% |
| 2017-03-31Q1 FY2017 | 2017-05-10 | $-1.00 | $3.6M | — | — | $-0.98 | -2.0% |
| 2016-12-31Q4 FY2016 | 2017-02-23 | $-1.22 | $1.3M | — | — | $-1.13 | -8.0% |
| 2016-09-30Q3 FY2016 | 2016-11-08 | $-1.24 | $661,000 | — | — | $-1.14 | -8.8% |
Need HRTX data in your own agent or pipeline?
The earnings data on this page — report dates, filed EPS/revenue actuals and run-rate history — is also available programmatically through the EvidInvest MCP server & financial data API for Claude, Cursor, or any MCP client and HTTP pipeline.